Table 2.
At least 1 aldosterone (ng/dL) | % of patients | At least 2 aldosterone levels (ng/dL) | % of patients | Mean aldosterone (ng/dL) | % of patients |
---|---|---|---|---|---|
< 10 | 29% | < 10 | 4% | < 10 | 4% |
< 15 | 49% | < 15 | 29% | < 15 | 33% |
< 20 | 69% | < 20 | 43% | < 20 | 53% |
At least 1 aldosterone (ng/dL) | % of patients | At least 2 aldosterone levels (ng/dL) | % of patients | Mean aldosterone (ng/dL) | % of patients |
---|---|---|---|---|---|
< 10 | 29% | < 10 | 4% | < 10 | 4% |
< 15 | 49% | < 15 | 29% | < 15 | 33% |
< 20 | 69% | < 20 | 43% | < 20 | 53% |